Robotic approach for the treatment of gynecological cancers recurrences: A ten-year single-institution experience
Camilla Certelli(Università Cattolica del Sacro Cuore), Valerio Gallotta(Agostino Gemelli University Polyclinic), Nazario Foschi(Agostino Gemelli University Polyclinic), Francesco Fanfani(Agostino Gemelli University Polyclinic), Giovanni Scambia(Agostino Gemelli University Polyclinic), Vito Chiàntera(University of Palermo), Virginia Vargiu(Università Cattolica del Sacro Cuore), Claudio Lodoli(Agostino Gemelli University Polyclinic), Alex Federico(Agostino Gemelli University Polyclinic), Agostino Maria De Rose(Agostino Gemelli University Polyclinic), Lucia Tortorella(Agostino Gemelli University Polyclinic), Matteo Bruno(Università Cattolica del Sacro Cuore), Riccardo Oliva(Università Cattolica del Sacro Cuore), Francesco Ardito(Agostino Gemelli University Polyclinic), Andrea Rosati(Agostino Gemelli University Polyclinic), Anna Fagotti(Agostino Gemelli University Polyclinic), Carmine Conte(Agostino Gemelli University Polyclinic), Luca Palmieri(Università Cattolica del Sacro Cuore), Francesco Santullo(Agostino Gemelli University Polyclinic)
Cited by 12
Related Papers
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2021|412
Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta‐analysis
|Ultrasound in Obstetrics and Gynecology|2017|299
SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer
|International Journal of Gynecological Cancer|2020|298
ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease
|Annals of Oncology|2024|277
Uterine serous carcinoma
|Gynecologic Oncology|2021|158